IAIM
LXRX icon

International Assets Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

International Assets Investment Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-785
Closed -$3K – 1284
2021
Q1 		$3K Hold
785
– – ﹤0.01% 1942
2020
Q4 		$3K Buy
+785
New +$1.5K ﹤0.01% 1797

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

International Assets Investment Management's LXRX Position: Q2 2021 in Review

International Assets Investment Management sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2021, closing a stake of 785 shares — an estimated $3K sold.

International Assets Investment Management first reported a position in LXRX in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q1 2021. 107 funds tracked by Wall St. Rank hold LXRX as of Q2 2021.

  • International Assets Investment Management reported no remaining Lexicon Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 785 Lexicon Pharmaceuticals shares in Q2 2021, an estimated $3K.
  • International Assets Investment Management first reported a position in Lexicon Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Lexicon Pharmaceuticals position peaked at $3K in Q1 2021.
  • 107 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.